流感板块午后再度拉升

Group 1 - Capbio experienced a 20% limit-up increase, indicating strong market performance [1] - Zhifei Biological and Wanfu Biological both saw increases exceeding 10%, reflecting positive investor sentiment [1] - Zhijiang Biological and Hualan Vaccine previously reached limit-up, showcasing significant market interest [1] Group 2 - Companies such as CanSino, Shuoshi Biological, and Kehua Biological also reported notable gains, indicating a broader trend in the sector [1]